Project Grant R35GM155107
Award Date
8/1/24
Completion Date
5/31/29
Dollars Obligated
$1.2M
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This Project Grant award of $462,000.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to establish the epigenetic mechanisms of gene regulation that govern the biology of embryonic stem cells (ESCs). The research aims to: 1) Dissect the molecular and biological requirements of TET-driven DNA hydroxylation versus formylation/carboxylation in ESC biology; and 2) Identify readers...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $2,586,600.00 in funding to the Van Andel Research Institute (VAI) to study the molecular mechanisms of chromatin signaling and epigenetic regulation. The key objectives of this 5-year award are to: 1) define regulatory and pathologic mechanisms connecting ubiquitin signaling to the epigenetic inheritance of DNA methylation;...
The National Institute of General Medical Sciences (NIGMS) awarded a $810,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The University of Texas MD Anderson Cancer Center. The project aims to broadly understand the biological roles of arginine methylation, a common post-translational modification, by characterizing the interaction between a novel reader protein (SART3) and arginine methylation marks, as well as investigating the functions of two...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) totals $408,750 and is effective from September 15, 2024 through July 31, 2029. The award will support the development of large-scale composite hypothesis testing approaches for performing translational genetics analyses. Specifically, the research will focus on creating interpretable and robust statistical methods for...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $445,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Beckman Research Institute of the City of Hope. The grant supports research to elucidate the molecular mechanisms by which protein arginine methylation regulates gene expression, RNA metabolism, and cellular processes, with the goal of advancing understanding of the role of this post-translational modification in...
The National Institute of General Medical Sciences (NIGMS) awarded a $294,647 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Texas at Dallas (UTD). The grant will fund a 4-year project from September 1, 2024 to August 31, 2028 to develop a theoretical, computational, and experimental framework for modeling epigenetic regulatory networks in human cells. The key objectives are to rapidly assemble and stably integrate libraries of...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $358,000 in funding to Brigham & Women's Hospital Inc. to conduct research on overcoming epigenetic barriers to somatic cell reprogramming by the XPC DNA repair complex. The key focus of the research is to understand how the XPC protein regulates DNA demethylation and gene expression changes mediated by the TDG enzyme, and how...
The National Institute of General Medical Sciences (NIGMS) awarded a $508,750 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to St. Jude Children's Research Hospital Inc. to uncover the epigenetic mechanisms that underlie stem cell fates during embryogenesis. The research aims to examine how histone H3 lysine 27 (H3K27) modifiers, such as PRC2 and UTX, respond to intrinsic and external cues to dynamically change H3K27 marks, regulate gene expression, and control cell...
This $999,999 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research at the Donald Danforth Plant Science Center to elucidate the mechanisms initiating de novo chromatin modification cycles in plant cells. Over three years, the award will support experiments using cutting-edge techniques to dissect the molecular triggers establishing heritable DNA methylation patterns and long-term epigenetic silencing of transposable elements and...
This $950,000 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research at Texas A&M University to investigate the molecular mechanisms underlying DNA demethylation processes mediated by the enzyme thymine DNA glycosylase (TDG). The project aims to uncover how TDG binds to and interacts with RNA to regulate its DNA demethylation functions, which are critical for maintaining proper genetic and epigenetic states in cells. The...